or Try an Advanced Search...

    Technical Analysis for NSPR - InspireMD, Inc.

    Grade Last Price % Change Price Change
    F 2.11 -0.47% -0.01
    NSPR closed down 0.47 percent on Wednesday, May 8, 2024, on 19 percent of normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
    Earnings due: May 14
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical NSPR trend table...
    Date Alert Name Type % Chg
    Shooting Star Candlestick Bearish 0.00%
    Lizard Bearish Bearish Day Trade Setup 0.00%
    Doji - Bearish? Reversal 0.00%
    20 DMA Support Bullish -0.47%
    Outside Day Range Expansion -0.47%
    Crossed Above 20 DMA Bullish -0.47%
    Gapped Up Strength -0.47%
    Wide Bands Range Expansion 5.50%
    Gapped Up Strength 5.50%
    MACD Bullish Signal Line Cross Bullish 4.98%
    Older End-of-Day Signals for NSPR ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 6 hours ago
    Up 3% about 9 hours ago
    Up 2% about 9 hours ago
    Up 1% about 9 hours ago
    Up 2% 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    NSPR Chart by TradingView
    Basic chart:

    Profile

    InspireMD Inc., a medical device company, focuses on the development and commercialization of proprietary MGuard stent platform technology. Its lead products include MGuard stent, an embolic protection device based on a protective sleeve, which is constructed out of an ultra-thin polymer mesh and wrapped around the stent; and MGuard Prime, which include its mesh sleeve wrapped around a cobalt-chromium stent. The company markets its products for use primarily in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack), and saphenous vein graft coronary interventions (bypass surgery). It sells its products through distributors in Europe, southeast Asia, India, and Latin America. InspireMD Inc. was founded in 2005 and is headquartered in Tel Aviv, Israel.
    Classification
    Sector: Healthcare
    Industry: Medical Devices
    Keywords: Medicine Medical Device Interventional Radiology Platform Technology Cobalt Veins Bypass Syndromes Circulatory System Interventional Cardiology Heart Attack Stent Bypass Surgery Embolic Protection Device Infarction Myocardial Infarction Percutaneous Coronary Intervention

    Is NSPR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 7 InspireMD to Report First Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, May 14th
    Apr 3 InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference
    Mar 31 InspireMD's (NASDAQ:NSPR) investors will be pleased with their solid 110% return over the last year
    Mar 26 InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024
    Mar 7 InspireMD, Inc. (NASDAQ:NSPR) Q4 2023 Earnings Call Transcript
    Mar 6 InspireMD Inc. (NSPR) Q4 2023 Earnings Call Transcript
    Mar 6 InspireMD GAAP EPS of -$0.16 beats by $0.03, revenue of $1.76M beats by $0.13M
    Mar 6 InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
    Mar 5 InspireMD Q4 2023 Earnings Preview
    Feb 28 InspireMD to Report Fourth Quarter and Full-Year 2023 Financial Results and Provide Corporate Business Update on Wednesday, March 6th
    See more NSPR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.85
    52 Week Low 1.2951
    Average Volume 38,831
    200-Day Moving Average 2.82
    50-Day Moving Average 2.28
    20-Day Moving Average 2.07
    10-Day Moving Average 2.01
    Average True Range 0.14
    RSI (14) 48.98
    ADX 19.83
    +DI 16.81
    -DI 20.49
    Chandelier Exit (Long, 3 ATRs) 2.03
    Chandelier Exit (Short, 3 ATRs) 2.23
    Upper Bollinger Bands 2.36
    Lower Bollinger Band 1.79
    Percent B (%b) 0.57
    BandWidth 27.63
    MACD Line -0.06
    MACD Signal Line -0.09
    MACD Histogram 0.0292
    Fundamentals Value
    Market Cap 45.47 Million
    Num Shares 21.5 Million
    EPS -1.29
    Price-to-Earnings (P/E) Ratio -1.64
    Price-to-Sales 10.83
    Price-to-Book 1.38
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.31
    Resistance 3 (R3) 2.32 2.28 2.27
    Resistance 2 (R2) 2.28 2.23 2.27 2.26
    Resistance 1 (R1) 2.19 2.20 2.24 2.18 2.25
    Pivot Point 2.15 2.15 2.17 2.14 2.15
    Support 1 (S1) 2.06 2.10 2.11 2.05 1.97
    Support 2 (S2) 2.02 2.07 2.01 1.96
    Support 3 (S3) 1.93 2.02 1.95
    Support 4 (S4) 1.92